Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NF-kappa-B-repressing factor (NKRF) is a transcription factor encoded by the NKRF gene in humans. It mediates transcriptional repression of certain NF-κB-responsive genes by interacting with specific negative regulatory elements (NREs)[1]. NKRF localizes predominantly to the nucleolus, with a smaller pool found in the nucleoplasm and cytoplasm[1][3][4]. In addition to its classical role as a transcriptional repressor, NKRF interacts with the 5′–3′ exoribonuclease XRN2, forming a complex required for proper ribosomal RNA precursor processing and ribosome biogenesis[3][4]. NKRF also acts as a nucleolar heat shock protein (HSP), regulating nucleolar homeostasis and cell survival during proteotoxic stress[4]. Disruption of NKRF function may impact NF-κB signaling, ribosome assembly, and cellular responses to stress, linking it to fundamental processes in inflammation, stress response, and potentially disease states such as cancer and inflammatory disorders[2][4].
Transcriptional repression of specific target genes by binding to negative regulatory elements, functional interaction with exoribonuclease XRN2 to regulate rRNA processing
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NF-kappa-B-repressing factor (NKRF).